Cantor Fitzgerald, L. P. »

Theravance Biopharma shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2023-12-31 $202k 18k 11.24
2023-09-30 $173k 20k 8.63
2023-06-30 $207k 20k 10.35
2023-03-31 $217k 20k 10.85

More positions owned by Cantor Fitzgerald, L. P.

Acelrx Pharmaceuticals Com New (TLPH)
Ramaco Res Com Cl A (METC)
Gcm Grosvenor Com Cl A (GCMG)
Senseonics Hldgs (SENS)
Rumble Com Cl A (RUM)
22nd Centy Group Com New (XXII)
Proshares Tr Ultrapro Qqq (TQQQ)
Xbp Europe Holdings (XBP)
Wework Cl A New (WEWKQ)
Moneyhero Ord Shs (MNY)
Meta Platforms Cl A (META)
Satellogic Class A Ord Shs (SATL)
GSK Sponsored Adr (GSK)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding Theravance Biopharma

Weiss Asset Management LP[1
Madison Avenue Partners
Vanguard Group
Newtyn Management
Park West Asset Management
D. E. Shaw & Co
Bank of America Corporation
Jacobs Levy Equity Management
Jane Street
Charles Schwab Investment Management
Wellington Management Company
Goldman Sachs Group
Chescapmanager
SG Americas Securities
Highbridge Capital Management

View all funds holding Theravance Biopharma